Estimating the Effect of PrEP in Black Men Who Have Sex with Men: A Framework to Utilize Data from Multiple Non-Randomized Studies to Estimate Causal Effects.

Black men who have sex with men (MSM) HIV causal inference non-randomized trials pre-exposure prophylaxis (PrEP)

Journal

medRxiv : the preprint server for health sciences
Titre abrégé: medRxiv
Pays: United States
ID NLM: 101767986

Informations de publication

Date de publication:
05 Mar 2024
Historique:
pubmed: 23 1 2024
medline: 23 1 2024
entrez: 23 1 2024
Statut: epublish

Résumé

Black men who have sex with men (MSM) are disproportionately burdened by the HIV epidemic in the US. The effectiveness of pre-exposure prophylaxis (PrEP) in preventing HIV infection has been demonstrated through randomized placebo-controlled clinical trials in several populations. Importantly, no such trial has been conducted exclusively among Black MSM in the US, and it would be unethical and infeasible to do so now. To estimate the causal effects of PrEP access, initiation, and adherence on HIV risk, we utilized causal inference methods to combine data from two non-randomized studies that exclusively enrolled Black MSM. The estimated relative risks of HIV were: (i) 0.52 (95% confidence interval: 0.21, 1.22) for individuals with versus without PrEP access, (ii) 0.48 (0.12, 0.89) for individuals who initiated PrEP but were not adherent versus those who did not initiate, and (iii) 0.23 (0.02, 0.80) for individuals who were adherent to PrEP versus those who did not initiate. Beyond addressing the knowledge gap around the effect of PrEP in Black MSM in the US, which may have ramifications for public health, we have provided a framework to combine data from multiple non-randomized studies to estimate causal effects, which has broad utility.

Identifiants

pubmed: 38260494
doi: 10.1101/2024.01.10.24301113
pmc: PMC10802753
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NIAID NIH HHS
ID : UM1 AI069412
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL146242
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI068619
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI068613
Pays : United States
Organisme : NIMH NIH HHS
ID : P30 MH123248
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI068617
Pays : United States

Références

N Engl J Med. 2012 Aug 2;367(5):423-34
pubmed: 22784038
AIDS Res Hum Retroviruses. 2016 Jan;32(1):32-43
pubmed: 26414912
Int J Epidemiol. 2015 Oct;44(5):1731-7
pubmed: 26210611
Am J Epidemiol. 2016 Apr 15;183(8):758-64
pubmed: 26994063
J Epidemiol. 2021 Aug 5;31(8):457-463
pubmed: 34121051
J Acquir Immune Defic Syndr. 2016 May 1;72(1):79-86
pubmed: 26745827
Lancet. 2013 Jun 15;381(9883):2083-90
pubmed: 23769234
Am J Public Health. 2015 Jan;105(1):122-131
pubmed: 24832150
J Acquir Immune Defic Syndr. 2014 Feb 1;65(2):218-25
pubmed: 24091691
J Int AIDS Soc. 2019 Feb;22(2):e25223
pubmed: 30768776
Stat Med. 2002 Jun 30;21(12):1689-709
pubmed: 12111906
N Engl J Med. 2015 Feb 5;372(6):509-18
pubmed: 25651245
AIDS Behav. 2017 Oct;21(10):2958-2972
pubmed: 28352984
Lancet. 2012 Jul 28;380(9839):341-8
pubmed: 22819656
Int J STD AIDS. 2017 May;28(6):602-607
pubmed: 27389778
Biometrics. 2003 Mar;59(1):152-62
pubmed: 12762452
J Acquir Immune Defic Syndr. 2014 Jul 1;66(3):340-8
pubmed: 24784763
Am J Epidemiol. 2006 Jun 15;163(12):1149-56
pubmed: 16624967
N Engl J Med. 2012 Aug 2;367(5):411-22
pubmed: 22784040
N Engl J Med. 2010 Dec 30;363(27):2587-99
pubmed: 21091279
PLoS One. 2013 Jul 26;8(7):e70413
pubmed: 23922989
Arthritis Rheumatol. 2015 Mar;67(3):609-11
pubmed: 25371384
Int J Biostat. 2010;6(2):Article 13
pubmed: 21969997
PLoS One. 2014 Jan 31;9(1):e87298
pubmed: 24498067
Epidemiology. 2003 Nov;14(6):680-6
pubmed: 14569183
Eur J Epidemiol. 2019 Jan;34(1):23-36
pubmed: 30341708
Lifetime Data Anal. 2009 Jun;15(2):278-94
pubmed: 19109770
Neuroepidemiology. 2009;32(3):229-39
pubmed: 19176974
Eur J Epidemiol. 2012 Feb;27(2):77-83
pubmed: 22160333
Stat Med. 2004 Mar 15;23(5):749-67
pubmed: 14981673
Stat Med. 2007 Feb 20;26(4):734-53
pubmed: 16708349
BMC Med Res Methodol. 2016 Nov 3;16(1):148
pubmed: 27809784
Int J Epidemiol. 2017 Apr 1;46(2):756-762
pubmed: 28039382
J Urban Health. 2016 Feb;93(1):170-88
pubmed: 26830422
AIDS Educ Prev. 2019 Oct;31(5):452-462
pubmed: 31550196
AIDS Care. 2021 May;33(5):633-638
pubmed: 32835494
J Natl Med Assoc. 2004 Jan;96(1):97-107
pubmed: 14746359
Int J Biostat. 2010;6(2):Article 14
pubmed: 21969998
AIDS. 2013 Aug 24;27(13):2155-60
pubmed: 24384592
Multivariate Behav Res. 2011 May;46(3):399-424
pubmed: 21818162
J Policy Anal Manage. 2013 Winter;32(1):107-121
pubmed: 25152557
AIDS Behav. 2014 May;18(5):972-96
pubmed: 24531769
N Engl J Med. 2015 Dec 3;373(23):2237-46
pubmed: 26624850
Epidemiology. 2000 Sep;11(5):550-60
pubmed: 10955408
N Engl J Med. 2012 Aug 2;367(5):399-410
pubmed: 22784037
Am J Epidemiol. 2022 May 20;191(6):1092-1097
pubmed: 35106534
Am J Epidemiol. 2003 Oct 1;158(7):687-94
pubmed: 14507605
Epidemiology. 2000 Sep;11(5):561-70
pubmed: 10955409

Auteurs

Allison Meisner (A)

Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, US.

Fan Xia (F)

Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, US.

Kwun C G Chan (KCG)

Department of Biostatistics, University of Washington, Seattle, WA, US.

Kenneth Mayer (K)

Harvard Medical School, Boston, MA, US.
Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA, US.
The Fenway Institute, Boston, MA, US.
Infectious Diseases Division, Beth Israel Deaconess Medical Center, Boston, MA, US.

Darrell Wheeler (D)

State University of New York at New Paltz, New Paltz, NY, US.

Sahar Zangeneh (S)

RTI International, Research Triangle Park, NC, US.
School of Public Health, University of Washington, Seattle, WA, US.

Deborah Donnell (D)

Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, WA, US.
Department of Global Health, University of Washington, Seattle, WA, US.

Classifications MeSH